Many things about Novel Coronavirus are spreading rapidly through social media, WhatsApp and the Internet. Some of these could be true, but many of those informations are baseless. At a time when the coronavirus epidemic is spreading across the world, it is important to know about some facts related to this deadly virus.
ABOUT AUTHOR
Dr. R. S. Thakur
Email: drramsthakur@gmail.com
Phone: +91-9740802164
Preamble
Health has direct impact on socio-economic growth of the country and welfare of its people. Hospital Pharmacy of a Hospital or other Health Care Facilities makes available drugs, devices, and other materials used in the diagnosis, mitigation, prevention and treatment of injury, illness, and disease. Hospital Pharmacy procures, stores and supplies medicines for dispensing, compounding, distribution and provides Pharmaceutical Care. Talking from a patient’s perspective, hospital pharmacy services provide medicines, information and advice to inpatients and outpatients as well as to the health professionals and others giving health care to the patients.
The cabinet has approved four schemes which totally include Rs 13,760 crore to promote the domestic production of active pharmaceutical ingredients (APIs) and medical devices in the country and their exports.
Here, we have presented with Facts of corona virus (COVID-19) as per World Health Organization (WHO). Do not be panic and follow the instructions by government and other health authorities
Foreign direct investment (FDI) is continuously declining in India. It is second time since 2014, there is a steady decline reported in 2019-20. It was Rs. 9994 crores in 2014-15 and declined to Rs. 2496 crore in 2019-2020 as reported by department of pharmaceuticals.
The pharmaceutical industry in India was valued at US$ 33 billion in 2017 and generic drugs account for 20 percent of global exports in terms of volume, making the country the largest provider of generic medicines globally.
Mergers and acquisitions (M&As) are perpetual part of big pharmaceutical industries and we have witnessed many such mergers and acquisitions. The financial crisis and resulting uncertainty in the global economies has made it difficult for companies to predict future performance of their own or their target’s or to forecast synergies and other transaction benefits with the same level of confidence seen in the past. As a result, acquirors and targets have developed transaction structures that are aimed at bridging gaps in their respective assessments of valuation and risk.
This article is focusing on top Pharmaceutical M&As of the year 2019.
Antibiotic resistance (AMR) is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Antimicrobial Resistance is an increasingly serious threat to public health. The spread of multi-drug resistant bacteria and the lack of new antibiotics to treat infections caused by these organisms pose a rapidly increasing threat to human health which urgently needs to be tackled.
Copyright © 2008-2020, PharmaTutor Edu Labs
.png)
.png)